Reproductive rights

Women’s health is not niche: It’s the future of healthcare

Just a few years ago, so many conversations around women’s health in the U.S. felt like they were still just making the case for why investment mattered. Panels, white papers, TED-style talks pointed to under-funding, data gaps, structural bias. But something has shifted. Across healthcare and investment communities, the tone now is more about when, not if,  and increasingly how.
Read More

KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version

Thttps://www.kff.org/health-information-trust/parents-trust-in-childrens-health-content-on-social-media-and-unfounded-claims-about-abortion-pill-safety/he latest release from the KFF/The Washington Post Survey of Parents, which finds that most parents report seeing children’s health content on social media, but many are unsure how to evaluate the trustworthiness of advice shared by health and wellness influencers. It also reviews misleading claims about the safety of medication abortion following the approval of a generic version of the abortion pill mifepristone, and it explores reports that federal officials are considering adding autism to the list of conditions covered by the Vaccine Injury Compensation Program.
Read More

Shield Laws for Reproductive and Gender-Affirming Health Care: A State Law Guide

After the Supreme Court overturned Roe v. Wade in June 2022 and eliminated the federal constitutional right to abortion, many states enacted bans and further restrictions on abortion. In response, states seeking to preserve and expand access to abortion have passed shield laws: legal protections for patients, health care providers, and people assisting in the provision of certain health care in states where that care is legal from the reach of states with civil, criminal, and professional consequences related to that care.
Read More

Trump announces a deal with a manufacturer to make a common fertility drug cheaper for IVF patients

The White House and EMD Serono said the drug, along with all its other IVF medications, will be available at a discount on TrumpRx, a government website where patients will be able to buy drugs directly from manufacturers. The Trump administration contends that the new website, which is expected to be running in 2026, will cut pharmaceutical costs by allowing people to buy them without a middleman.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.